DK1492767T3 - Visse 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer af serinproteasefaktoren XA - Google Patents

Visse 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer af serinproteasefaktoren XA

Info

Publication number
DK1492767T3
DK1492767T3 DK03714138T DK03714138T DK1492767T3 DK 1492767 T3 DK1492767 T3 DK 1492767T3 DK 03714138 T DK03714138 T DK 03714138T DK 03714138 T DK03714138 T DK 03714138T DK 1492767 T3 DK1492767 T3 DK 1492767T3
Authority
DK
Denmark
Prior art keywords
inhibitors
cyclopropylglycinyl
piperidin
certain
serine protease
Prior art date
Application number
DK03714138T
Other languages
Danish (da)
English (en)
Inventor
Gary Lowell Engel
Michael Robert Wiley
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1492767T3 publication Critical patent/DK1492767T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/52Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03714138T 2002-04-01 2003-03-24 Visse 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer af serinproteasefaktoren XA DK1492767T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36852302P 2002-04-01 2002-04-01

Publications (1)

Publication Number Publication Date
DK1492767T3 true DK1492767T3 (da) 2005-11-28

Family

ID=28791889

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03714138T DK1492767T3 (da) 2002-04-01 2003-03-24 Visse 1-(D-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazinforbindelser som inhibitorer af serinproteasefaktoren XA

Country Status (25)

Country Link
US (1) US7166606B2 (es)
EP (1) EP1492767B1 (es)
JP (1) JP2005531529A (es)
KR (1) KR20040094892A (es)
CN (1) CN1288135C (es)
AT (1) ATE303990T1 (es)
AU (1) AU2003218147A1 (es)
BR (1) BR0308870A (es)
CA (1) CA2478340A1 (es)
CR (1) CR7497A (es)
DE (1) DE60301569T2 (es)
DK (1) DK1492767T3 (es)
EA (1) EA007300B1 (es)
EC (1) ECSP045329A (es)
ES (1) ES2248737T3 (es)
HK (1) HK1070363A1 (es)
HR (1) HRP20040900B1 (es)
IL (1) IL164018A0 (es)
MX (1) MXPA04009640A (es)
NO (1) NO20044688L (es)
NZ (1) NZ535402A (es)
PL (1) PL373066A1 (es)
UA (1) UA76849C2 (es)
WO (1) WO2003084929A1 (es)
ZA (1) ZA200407418B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6834308B1 (en) 2000-02-17 2004-12-21 Audible Magic Corporation Method and apparatus for identifying media content presented on a media playing device
US7363278B2 (en) 2001-04-05 2008-04-22 Audible Magic Corporation Copyright detection and protection system and method
US8972481B2 (en) 2001-07-20 2015-03-03 Audible Magic, Inc. Playlist generation method and apparatus
DE102014108210A1 (de) 2014-06-11 2015-12-17 Dietrich Gulba Rodentizid
US11014920B2 (en) 2016-11-18 2021-05-25 Merck Sharp & Dohme Corp. Factor XIIa inhibitors
EP4070658A1 (de) 2021-04-06 2022-10-12 BIORoxx GmbH Verwendung von blutgerinnungshemmenden verbindungen als rodentizide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000077027A2 (en) 1999-06-14 2000-12-21 Tularik Limited Serine protease inhibitors
AU8875798A (en) 1997-08-29 1999-03-22 Proteus Molecular Design Ltd Meta-benzamidine derivatives as serin protease inhibitors
EP1192132B1 (en) 1999-06-14 2005-09-07 Eli Lilly And Company Serine protease inhibitors
GB0030303D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030304D0 (en) * 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030305D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
GB0030306D0 (en) 2000-12-13 2001-01-24 Lilly Co Eli Compounds
TWI257389B (en) 2001-06-12 2006-07-01 Lilly Co Eli Pharmaceutical compound
ES2298386T3 (es) * 2001-07-26 2008-05-16 Eli Lilly And Company 1-glicinil-4-(1-metilpiperidin-4-il)piperazinas y -piperidinas como antagonistas del factor xa.

Also Published As

Publication number Publication date
KR20040094892A (ko) 2004-11-10
HRP20040900A2 (en) 2004-12-31
WO2003084929A1 (en) 2003-10-16
NZ535402A (en) 2006-02-24
ES2248737T3 (es) 2006-03-16
DE60301569D1 (de) 2005-10-13
EP1492767B1 (en) 2005-09-07
ATE303990T1 (de) 2005-09-15
IL164018A0 (en) 2005-12-18
UA76849C2 (uk) 2006-09-15
DE60301569T2 (de) 2006-06-14
CA2478340A1 (en) 2003-10-16
US7166606B2 (en) 2007-01-23
EP1492767A1 (en) 2005-01-05
MXPA04009640A (es) 2005-01-11
ECSP045329A (es) 2004-11-26
CR7497A (es) 2005-01-17
EA007300B1 (ru) 2006-08-25
AU2003218147A1 (en) 2003-10-20
JP2005531529A (ja) 2005-10-20
BR0308870A (pt) 2005-01-04
US20050096328A1 (en) 2005-05-05
PL373066A1 (en) 2005-08-08
CN1642914A (zh) 2005-07-20
EA200401290A1 (ru) 2005-02-24
NO20044688L (no) 2004-10-29
HRP20040900B1 (en) 2006-02-28
CN1288135C (zh) 2006-12-06
WO2003084929A8 (en) 2004-05-21
HK1070363A1 (en) 2005-06-17
ZA200407418B (en) 2005-09-15

Similar Documents

Publication Publication Date Title
NO20060847L (no) Substituert 2-aminotetralin til behandling av depresjon
IS7718A (is) Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar
DK1836201T3 (da) Pyrrolidininhibitorer af IAP
NO20062021L (no) Omleirede pentanoler, fremgangsmpte for fremstilling av dette, og deres anvendelse som antiflogistika
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
IS6902A (is) N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl
WO2006047528A3 (en) Pyrazolobenzamides and derivatives as factor xa inhibitors
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
NO20062892L (no) 7-fenylalkyl-substituert 2-kinolinoner og 2-kinoksalinoner som poly(adp-ribose)-polymeraseinhibitorer
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
NO20082629L (no) Macrocyklisk factor VIIa-inhibitorer anvendbare som antikoagulanter
GB0426313D0 (en) Therapeutic agents
WO2004031145A3 (en) Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
HK1070363A1 (en) Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa
NO20064491L (no) Nye difluomtoksysubstituee hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer
NO20055396D0 (no) Nye fosfonsyreforbindelser som erinproteaseinhibitorer
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
MY137876A (en) Pharmaceutical compound
DE602005005638D1 (de) 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-on-derivate als pde4-inhibitoren
DK1637141T3 (da) Stabiliseret proteasesammensætning omfattende en serinprotease, morpholinderivater og reversible inhibitorer af serinproteasen
EA200700186A1 (ru) Фармацевтическое соединение
DE60224805D1 (de) 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine un
HRP20030653B1 (en) Novel benzoylguanidine salt
SI1492767T1 (sl) Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze